| GB1381872A
              (en)
            
            * | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation | 
        
          | BE787100A
              (fr)
            
            * | 1971-08-06 | 1973-02-02 | Beecham Group Ltd | Composition pour le traitement de l'asthme | 
        
          | GB1410588A
              (en)
            
            * | 1971-08-10 | 1975-10-22 | Fisons Ltd | Composition | 
        
          | DE2332663C2
              (de)
            
            * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie | 
        
          | DE2535258C2
              (de)
            
            * | 1974-08-10 | 1993-06-03 | Fisons Plc, Ipswich, Suffolk | Inhalierbares Medikament in Pelletform | 
        
          | US4161516A
              (en)
            
            * | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease | 
        
          | IL51314A
              (en)
            
            * | 1976-01-30 | 1980-03-31 | Fisons Ltd | Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it | 
        
          | GB2077100B
              (en)
            
            * | 1980-04-30 | 1985-04-24 | Fisons Ltd | Pharmaceutical compositions containing cromoglycates | 
        
          | BE891013A
              (fr)
            
            * | 1980-11-05 | 1982-05-05 | Fisons Ltd | Compositions pharmaceutique | 
        
          | JPS59163313A
              (ja)
            
            * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 | 
        
          | US5204113A
              (en)
            
            * | 1987-04-09 | 1993-04-20 | Fisons Plc | Pharmaceutical compositions containing pentamidine | 
        
          | DE3872635T2
              (de)
            
            * | 1987-04-09 | 1992-12-17 | Fisons Plc | Pentamidin enthaltende pharmazeutische zusammensetzungen. | 
        
          | DE4140689B4
              (de)
            
            * | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung | 
        
          | KR100208979B1
              (ko)
            
            * | 1992-06-12 | 1999-07-15 | 야스이 쇼사꾸 | 기도내 투여용 제제 | 
        
          | US6632456B1
              (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation | 
        
          | US6794357B1
              (en) | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation | 
        
          | US5830853A
              (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation | 
        
          | EG20677A
              (en)
            
            * | 1993-10-01 | 1999-11-30 | Astra Ag | Method and an apparatus for micronizing the particle size | 
        
          | IS1736B
              (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna | 
        
          | NL9301851A
              (nl)
            
            * | 1993-10-26 | 1995-05-16 | Cordis Europ | Cryo-ablatie catheter. | 
        
          | GB9322014D0
              (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers | 
        
          | GB9404945D0
              (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition | 
        
          | US6102036A
              (en)
            
            * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler | 
        
          | US6165976A
              (en) | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation | 
        
          | DE4425255A1
              (de) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation | 
        
          | MY131733A
              (en) | 1994-12-22 | 2007-08-30 | Astra Ab | Aerosol drug formulations | 
        
          | US6524557B1
              (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins | 
        
          | HU218940B
              (hu) | 1994-12-22 | 2001-01-29 | Astra Aktiebolag | Paratiroid hormont (PHT) tartalmazó, inhalációs célra szolgáló gyógyszerkészítmény, eljárás előállítására, alkalmazása inhalációs készülék töltésére és ezt tartalmazó inhalációs készülék | 
        
          | GB9501841D0
              (en)
            
            * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers | 
        
          | DK0986413T3
              (da)
            
            * | 1997-05-27 | 2004-09-20 | Direct Haler As | Anordning til indföring af en pulverformet eller partikelformet substans i en persons næsebor | 
        
          | ATE399541T1
              (de)
            
            * | 1998-08-18 | 2008-07-15 | Univ California | Epidermale wachstumsfaktor rezeptor antagonisten zur behandlung stark vermehrter schleimsekretion in der lunge | 
        
          | US7354894B2
              (en) | 1998-08-18 | 2008-04-08 | The Regents Of The University Of California | Preventing airway mucus production by administration of EGF-R antagonists | 
        
          | IL146886A0
              (en) | 1999-06-05 | 2002-08-14 | Innovata Biomed Ltd | Medicament delivery system | 
        
          | ITMI991582A1
              (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala | 
        
          | GB9920839D0
              (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler | 
        
          | EP1129705A1
              (en)
            
            * | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation | 
        
          | PE20011227A1
              (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros | 
        
          | GB0009469D0
              (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices | 
        
          | BR0107304A
              (pt)
            
            * | 2000-10-12 | 2002-08-13 | Boehringer Ingelheim Pharma | Pó para inalação contendo tiotrópio | 
        
          | UA75375C2
              (en)
            
            * | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling | 
        
          | US20060194773A1
              (en)
            
            * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities | 
        
          | DE10141377A1
              (de) | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen | 
        
          | EP1487417A4
              (en)
            
            * | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS | 
        
          | AU2002346424A1
              (en)
            
            * | 2001-11-19 | 2003-06-10 | Becton, Dickinson And Company | Pharmaceutical compositions in particulate form | 
        
          | GB0128148D0
              (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly | 
        
          | US6900317B2
              (en) | 2002-02-19 | 2005-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them | 
        
          | US20040014679A1
              (en)
            
            * | 2002-02-20 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof | 
        
          | DE10207026A1
              (de)
            
            * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung | 
        
          | JP2006516531A
              (ja)
            
            * | 2002-08-21 | 2006-07-06 | ノートン ヘルスケアー リミテッド | 吸入組成物 | 
        
          | DE10255387A1
              (de)
            
            * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation | 
        
          | US7763280B2
              (en)
            
            * | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation | 
        
          | DE10317461A1
              (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung | 
        
          | DE10338407A1
              (de)
            
            * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Inhalationspulver enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin | 
        
          | US20050042178A1
              (en)
            
            * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder | 
        
          | DE10338403A1
              (de)
            
            * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum | 
        
          | DE10338402A1
              (de)
            
            * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum | 
        
          | US20050042179A1
              (en)
            
            * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine | 
        
          | DE10338399A1
              (de)
            
            * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mikropartikel, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-Iysyl]-4-(4-pyridinyl)-piperazin, Verfahren zu deren Herstellung sowie deren Verwendung als Inhalaltionspulver | 
        
          | US20050043247A1
              (en)
            
            * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative | 
        
          | DK1699434T3
              (da) | 2003-09-02 | 2011-05-30 | Norton Healthcare Ltd | Fremgangsmåde til fremstilling af et lægemiddel | 
        
          | PE20050489A1
              (es) | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos | 
        
          | CA2562386C
              (en) | 2004-04-21 | 2014-11-18 | Innovata Biomed Limited | Inhaler | 
        
          | GB0409197D0
              (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device | 
        
          | TWI363759B
              (en) | 2004-04-27 | 2012-05-11 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists | 
        
          | US7611709B2
              (en)
            
            * | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives | 
        
          | US7723306B2
              (en)
            
            * | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation | 
        
          | US7727962B2
              (en)
            
            * | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation | 
        
          | DE102004048390A1
              (de)
            
            * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff | 
        
          | DE102004048389A1
              (de)
            
            * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa | 
        
          | JP5156397B2
              (ja)
            
            * | 2005-02-10 | 2013-03-06 | グラクソ  グループ  リミテッド | 予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤 | 
        
          | CN103145766B
              (zh) | 2008-07-24 | 2015-02-11 | 乔治洛德方法研究和开发液化空气有限公司 | 用于沉积含过渡金属的膜的杂配型环戊二烯基过渡金属前体 | 
        
          | US9925282B2
              (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment | 
        
          | PL3578169T3
              (pl) | 2009-02-26 | 2024-09-02 | Glaxo Group Limited | Preparaty farmaceutyczne zawierające 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol | 
        
          | GB0921075D0
              (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents | 
        
          | PT106094A
              (pt) | 2012-01-13 | 2013-07-15 | Hovione Farmaciencia S A | Administração por inalação de formulações com dose elevada | 
        
          | US20150165038A1
              (en)
            
            * | 2012-02-10 | 2015-06-18 | Arven llac Sanayi Ve Ticaret A.S. | Compositions comprising muscarinic receptor antagonist and sorbitol | 
        
          | US20150174064A1
              (en)
            
            * | 2012-07-05 | 2015-06-25 | Arven IIac Sanayi Ve Ticaret A.S. | Compositions comprising muscarinic receptor antagonist and glucose anhydrous | 
        
          | WO2014007772A2
              (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising glucose anhydrous | 
        
          | WO2014007771A2
              (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising muscarinic receptor antagonist | 
        
          | WO2014066318A1
              (en) | 2012-10-25 | 2014-05-01 | The General Hospital Corporation | Combination therapies for the treatment of alzheimer's disease and related disorders | 
        
          | GB201305825D0
              (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use | 
        
          | US10525005B2
              (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof | 
        
          | CN113768881A
              (zh) | 2013-10-08 | 2021-12-10 | 人工智能治疗公司 | 用于治疗淋巴管平滑肌瘤病的雷帕霉素 | 
        
          | CN110305095A
              (zh)
            
            * | 2013-10-22 | 2019-10-08 | 综合医院公司 | 色甘酸衍生物以及成像和治疗的相关方法 | 
        
          | MX394266B
              (es) | 2014-04-04 | 2025-03-24 | Ai Therapeutics Inc | Una formulacion de rapamicina inhalable para tratar afecciones relacionadas con la edad. | 
        
          | CA2963085C
              (en) | 2014-10-07 | 2023-02-21 | Lam Therapeutics, Inc. | An inhalable rapamycin formulation for the treatment of pulmonary hypertension | 
        
          | CN116889562A
              (zh) | 2016-08-31 | 2023-10-17 | 通用医疗公司 | 与神经退行性疾病相关的神经炎症中的巨噬细胞/小胶质细胞 | 
        
          | AU2018292732B2
              (en) | 2017-06-28 | 2024-07-04 | Philip Morris Products S.A. | Container with particles for use with inhaler | 
        
          | AU2017423862A1
              (en) | 2017-07-20 | 2020-02-06 | Aztherapies, Inc. | Powdered formulations of cromolyn sodium and ibuprofen | 
        
          | JP2021529771A
              (ja) | 2018-07-02 | 2021-11-04 | ザ ジェネラル ホスピタル コーポレイション | クロモリンナトリウムおよびα−ラクトースの粉末製剤 | 
        
          | PL3833964T3
              (pl) | 2018-08-07 | 2023-09-04 | Norton (Waterford) Limited | Zastosowanie spektroskopii ramana do produkcji proszków do inhalacji | 
        
          | JP2022515293A
              (ja) | 2018-12-10 | 2022-02-17 | ザ ジェネラル ホスピタル コーポレイション | クロモリンエステルおよびそれらの使用 | 
        
          | EP4203945A1
              (en) | 2020-08-28 | 2023-07-05 | Universität Linz | Use of leoligin in the prevention of tissue damage |